AKTX
Akari Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
AKTX Filings
Filing Date
Form Description
Form Type
2025-12-05
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-05 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-03
Form EFFECT - Notice of Effectiveness
2025-12-03 ·
Form EFFECT - Notice of Effectiveness
2025-11-26
Form 8-K - Current report
Key Events
2025-11-26 · Key Events
Form 8-K - Current report
2025-11-17
Form DEF 14A - Other definitive proxy statements
Key Events
2025-11-17 · Key Events
Form DEF 14A - Other definitive proxy statements
2025-11-17
Form S-1 - General form for registration of securities under the Securities Act of 1933
2025-11-17 ·
Form S-1 - General form for registration of securities under the Securities Act of 1933
2025-11-13
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-13 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-07
Form PRE 14A - Other preliminary proxy statements
Key Events
2025-11-07 · Key Events
Form PRE 14A - Other preliminary proxy statements
2025-11-04
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-04 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-10-24
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-10-24 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-10-24
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2025-10-24 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
